08 October 2010
UK-BASED SCM Pharma will use AAPS(booth 1746) to showcase its unique service offerings that are helping pharmaceutical firms across Europe and the US source GMP radio-labelled and highly potent finished dosage forms.
The contract manufacturing organisation (CMO) will use the New Orleans show as a platform to meet firms that are finding it difficult to identify manufacturing partners with the capability to sterile fill potent products such as cytotoxics and cytostatics for both clinical trials supply and the low volume supply of licensed drugs.
Having established a world-class reputation for clinical trial manufacturing, SCM Pharma launched its commercial supply service at CPhI 2009 and has since secured several long term contracts with firms in Europe regularly supplying niche commercially licensed products.
The company revealed that such projects have included the development and aseptic ampoule filling of a potent oncology product that is now being produced on an ongoing basis for Denmark-based specialty pharmaceutical company NordMedica.
The fill/finish specialist will also use the opportunity to illustrate how its radiopharma service, which involves the fill/finish of radio-labelled drug candidates, is helping companies such as sanofi-aventis.
Dianne Sharp, managing director at SCM Pharma, explains: “As we are licensed to handle Carbon 14 (C-14) compounds, this has enabled us to aseptically process radio-labelled drug products including intravenous presentations. This has allowed us to help our pharmaceutical customers carry out absorption, distribution, metabolism and excretion (ADME) studies at the pre-clinical or clinical trials stage to help speed-up the drug development cycle and reduce cost.
“We are very much about working in partnership with clients that require the manufacturing and filling of novel, difficult and dangerous finished drug products. We have assisted numerous clients over the last year alone and look forward to meeting new contacts at AAPS with equally as challenging sterile manufacturing requirements,” added Dianne.
To help promote its specialist services and adding an element of fun to this year’s event in Paris, the SCM Pharma team at booth 1746 will be accompanied by its very own superheroes that are here to help the pharma world – Potent Pete and Radioactive Ray.
SCM Pharma recently introduced Sterility and Bacterial Endotoxin Testing (BET) to its state-of-the-art facility, which are helping supplement its existing analytical, stability and microbiological testing capabilities.
The new testing services also complement its established in-house aseptic processing and terminal sterilisation capabilities that allows the company to fill ampoules, vials and syringes.
The CMO offers sterile and non-sterile production services to pharmaceutical, biotech and medical device companies across the world. The company has now worked with a third of the top ten global pharmaceutical firms on various product indications across a number of therapeutic areas.
ENDS
Picture caption: BOOM: SCM’s potent and radioactive additions
Media contact: Raman Sehgal at SCM Pharma
01661 838 186 / ramans@scm-pharma.com
